ARMATA PHARMACEUTICALS, INC. Other Receivables, Net, Current
ARMATA PHARMACEUTICALS, INC. (ARMP) had Other Receivables, Net, Current of $744.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-21.
Financial Statements › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2025-03-21
- 2024-12-31: Other Receivables, Net, Current $744.00K.
- 2024-09-30: Other Receivables, Net, Current $2.22M.
- 2024-06-30: Other Receivables, Net, Current $1.24M.
- 2024-03-31: Other Receivables, Net, Current $1.71M.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2024-12-31 | $744.00K 10-K · filed 2025-03-21 |
| 2024-09-30 | $2.22M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.24M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.71M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $3.36M 10-K · filed 2025-03-21 |
| 2023-09-30 | $8.50M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $8.63M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $8.53M 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |